AstraZeneca has dragged Dr Reddy's Laboratories to the court to protect its blood clot inhibitor drug Brilinta from generic competition
from Latest News https://ift.tt/2Kdnw7F
Tuesday, 31 July 2018
AstraZeneca-DRL patent case: Fate of Rs 2.35 bn drug to be decided today
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment